Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
Status:
Unknown status
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
A single-blind switching study in which forty subjects currently being treated with
risperidone will be randomly assigned to either stay on risperidone or switched to
quetiapine. Various behavioral and biological measures will be used to compare smoking
behavior over time in these two groups.